79426071 - AIXPLORE

Information

  • Trademark
  • 79426071
  • Serial Number
    79426071
  • Filing Date
    January 23, 2025
    9 months ago
  • Transaction Date
    July 10, 2025
    3 months ago
  • Status Date
    July 08, 2025
    3 months ago
  • Location Date
    July 08, 2025
    3 months ago
  • Status Code
    640
  • Current Location
    TMEG LAW OFFICE 104
    Employee Name
    HUDSON, TAMARA
  • Law Office Assigned Location Code
    L40
  • Owners
Mark Drawing Code
4
Mark Identification
AIXPLORE
Case File Statements
  • GS0091: Computer software used in the context of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; computer software used in the context of antibody discovery and identification; artificial intelligence software used in the context of drug discovery, affinity maturation, engineering of biological products, studies of molecular interactions, humanization and identification, drug research, antibody research and design, pharmaceutical research; machine learning software used in the context of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; downloadable software for research, diagnostics, genomics, proteomics, omics and biological products; big data generation software
  • PM0001: AI EXPLORE
  • GS0421: SAAS for use in the field of drug discovery, diagnostics, genetics, proteomics and identification, drug research, antibody, protein, peptide, biological product and chemical product research and design, pharmaceutical research; medicine discovery services; biological research; scientific services and research in the field of drug discovery, affinity maturation, biological product engineering, studies of molecular interactions, humanization and identification, drug research, antibody, protein, peptide, biological and chemical research and design, pharmaceutical research; antibody sequencing; research and development services related to AI in the field of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; research and development in the field of drug discovery and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals; research and development services in the field of antibody technology; electronic data storage and machine learning
Case File Event Statements
  • 6/22/2025 - 4 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/22/2025 - 4 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/8/2025 - 3 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/9/2025 - 3 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/19/2025 - 4 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 7/3/2025 - 4 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK